Resistance to EGFR inhibitors through histological transformation of lung EGFR-mutant adenocarcinoma to SCLC has been reported in 3%-14% of cases in repeated biopsies series[11,15-17]. This evidence concerns the gene EGFR and adenocarcinoma.